Physician profile
Robert H Blanton
NPI 1104921212
$424.39
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2020: $97.33 · 2021: $67.60 · 2022: $76.84.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Portola Pharmaceuticals, LLC | $58.86 | 2019 | |
| Medtronic Vascular, INC. | $48.26 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $42.94 | 2022 | |
| Davol INC. | $38.59 | 2020 | |
| Lemaitre Vascular, INC. | $34.02 | 2019 | |
| Convatec INC. | $33.82 | 2020-2021 | |
| Smith+Nephew, INC. | $31.66 | 2019 | |
| Intuitive Surgical, INC. | $19.22 | 2020 | |
| Kci USA, INC. | $18.89 | 2022 | |
| Elutia, INC. | $16.35 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $15.01 | 2022 | |
| Medtronic, INC. | $14.99 | 2021 | |
| Stryker Corporation | $14.36 | 2020 | |
| Teleflex LLC | $13.61 | 2021 | |
| Csl Behring | $11.92 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $11.89 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Blanton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.